These include the aryl hydrocarbon receptor (AHR), the progesterone receptor (PR), and, with particular relevance to macrophage‐rich tumor microenvironments, tumor‐associated macrophages (TAMs) (Salvagno et al., 2019; Walter et al., 2017; Yamada et al., 2016). The gene discussed is PGR; the disease is neoplasm.